SCHEMBL25490438

SCHEMBL25490438

Cc1ccc2c(c1)oc1c(C(C)(C)C)cccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ MAOB P27338 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ CDC25A P30304 1/20 0.35
▸ CDC25C P30307 1/20 0.35
▸ POLB P06746 3/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.34
▸ GABRA1 P14867 1/20 0.33
▸ GABRB2 P47870 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ KIF11 P52732 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16261661 0.87 MAPT (0.40) KMT2AMEN1CYP2C19ALDH1A1HPGD
SCHEMBL16273156 0.86 AR (0.40) KMT2AMEN1CYP2C19MAOBALDH1A1
SCHEMBL24421875 0.84 MEN1 (0.40) KMT2AMEN1CYP2C19ALDH1A1HPGD
SCHEMBL16185372 0.83 MEN1 (0.39) KMT2AMEN1CYP2C19DYRK1ATP53
SCHEMBL12411501 0.81 MEN1 (0.55) KMT2AMEN1CYP2C19ALDH1A1HPGD
SCHEMBL22252767 0.81 ALDH1A1 (0.39) KMT2AMEN1CYP2C19ALDH1A1GAA
SCHEMBL16282385 0.80 MEN1 (0.40) KMT2AMEN1CYP2C19ALDH1A1GAA
SCHEMBL14565445 0.80 CYP1A2 (0.46) MAOBALDH1A1GAAHPGDDYRK1A
SCHEMBL22645861 0.79 DYRK1A (0.42) KMT2AMEN1CYP2C19ALDH1A1HPGD
SCHEMBL25490443 0.79 CDC14B (0.39) KMT2AMEN1MAOBALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024013709-A1 COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2024-01-18 — — WO disclosed
US-20230159578-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159578-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, OPRD1, DRD3 KMT2A 4054/4885MEN1 2299/4885CYP2C19 1107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback